Granules India Ltd. Share Price NSE India S.E.
Equities
INE101D01012
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- INR | - |
05-15 | Transcript : Granules India Limited, Q4 2024 Earnings Call, May 15, 2024 | |
05-15 | Granules India Posts Decline in Fiscal Q4 Consolidated Net Profit, Revenue | MT |
Sales 2024 | 45.06B 540M 42.41B | Sales 2025 * | 51.28B 615M 48.25B | Capitalization | 101B 1.22B 95.37B |
---|---|---|---|---|---|
Net income 2024 | 4.05B 48.59M 3.81B | Net income 2025 * | 5.84B 70.06M 5.5B | EV / Sales 2024 | 2.31 x |
Net Debt 2024 * | 8.13B 97.42M 7.65B | Net Debt 2025 * | 7.96B 95.48M 7.49B | EV / Sales 2025 * | 2.13 x |
P/E ratio 2024 |
25.7
x | P/E ratio 2025 * |
17.6
x | Employees | - |
Yield 2024 * |
0.33% | Yield 2025 * |
0.33% | Free-Float | 53.27% |
Latest transcript on Granules India Ltd.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 04/01/22 | |
Chief Executive Officer | 69 | 17/03/91 | |
Mukesh Surana
DFI | Director of Finance/CFO | 44 | 29/12/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 18/02/13 | |
Director/Board Member | 62 | 12/12/21 | |
Arun Sawhney
BRD | Director/Board Member | 68 | 28/10/18 |
1st Jan change | Capi. | |
---|---|---|
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |